PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ministrio de Salud de la Nación Argentina, Buenos Aires, Argentina. Electronic address: arearte@msal.gov.ar.\', \'Ministrio de Salud de la Nación Argentina, Buenos Aires, Argentina.\', \'Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, Buenos Aires, Argentina.\', \'Hospital Privado de Comunidad, Escuela Superior de Medicina Universidad Nacional de Mar del Plata, Buenos Aires, Argentina.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(22)00011-310.1016/S0140-6736(22)00011-3
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 35303473
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all